亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

One-Year Outcome of Cardiac Contractility Modulation in Patients With Reduced Ejection Fraction, Atrial Fibrillation, and Previous Resynchronization: A Pilot Study

医学 射血分数 心脏病学 心力衰竭 内科学 心房颤动 心脏再同步化治疗 收缩性 糖尿病 内分泌学
作者
Diana Țînț,Sorin Micu
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:30 (1): e10-e16 被引量:1
标识
DOI:10.1097/mjt.0000000000001579
摘要

After 6 months of therapy, cardiac contractility modulation (CCM) has been shown to improve symptoms, exercise tolerance, and quality of life as well as reduce the rate of hospitalizations in patients with heart failure with reduced left ventricular ejection fraction (HFrEF), but long-term effects data are lacking, with no randomized trial to date.What is the long-term benefit of the CCM device implantation in symptomatic patients with severe, optimally treated HFrEF?We conducted a prospective trial involving patients with symptomatic HFrEF [New York Heart Association (NYHA) Class III or IV, left ventricular ejection fraction (LVEF) ≤35%] who were supported by a CCM device.Twenty patients (19 men), aged 66.5 ± 6.9 years, were provided with CCM therapy and followed up for an average duration of 321.7 ± 113.5 days. The etiology of heart failure was ischemic in 16 patients (80%), 9 patients (45%) had atrial fibrillation, 6 patients (30%) had diabetes mellitus, and mean creatinine clearance value was 54.8 ± 13.0 mL/min. Eleven patients (60%) had LVEF ≤25%. Although all the patients had an implanted cardioverter-defibrillator, 6 of them (30%) also had resynchronization therapy. The pharmacological treatment has been optimized in all patients. One year after implantation, the LVEF increased from 24.68% ± 4.5 to 34.6 ± 5 ( P < 0.0001), NYHA class improved from 3.2 ± 0.5 to 1.4 ± 0.5 ( P < 0.0001), and exercise tolerance evaluated with a 6-Minute Walk Test increased (from 307.9 ± 74.1 m to 567 ± 99.5 m; P < 0.00001). These improvements were largely seen in the first 6 months.Over the course of a year, CCM therapy was associated with improved LVEF and NYHA class, as well as significantly better exercise tolerance, even in patients with atrial fibrillation and cardiac resynchronization therapy and did not seem to be associated with additional significant device-related problems.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LAN完成签到,获得积分10
5秒前
sasa完成签到,获得积分10
5秒前
小何发布了新的文献求助10
7秒前
ooo完成签到,获得积分10
8秒前
其实完成签到,获得积分20
9秒前
Lionnn完成签到 ,获得积分10
11秒前
11秒前
chxxx完成签到,获得积分10
12秒前
may发布了新的文献求助10
17秒前
RR发布了新的文献求助10
38秒前
pp‘s完成签到 ,获得积分10
43秒前
骄傲的硬币完成签到,获得积分10
44秒前
喜悦宫苴完成签到,获得积分10
46秒前
xin_you完成签到,获得积分10
47秒前
49秒前
Yan完成签到,获得积分10
51秒前
合一海盗完成签到,获得积分10
53秒前
54秒前
Yucorn完成签到 ,获得积分10
58秒前
慕青应助RR采纳,获得10
1分钟前
水水水完成签到 ,获得积分10
1分钟前
春天在这李完成签到 ,获得积分10
1分钟前
孤独的涵柳完成签到 ,获得积分10
1分钟前
Cpp完成签到 ,获得积分10
1分钟前
凤里完成签到 ,获得积分10
1分钟前
彭于晏应助狮子清明尊采纳,获得10
1分钟前
Jasper应助wzm采纳,获得80
1分钟前
情怀应助心之所向采纳,获得30
1分钟前
fvsuar完成签到,获得积分10
1分钟前
nojego完成签到,获得积分10
1分钟前
所所应助fvsuar采纳,获得10
1分钟前
顾矜应助t12s2365_采纳,获得10
1分钟前
liuqi完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
t12s2365_完成签到 ,获得积分10
1分钟前
Seren完成签到 ,获得积分10
1分钟前
科研通AI2S应助狮子清明尊采纳,获得10
1分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 1370
Encyclopedia of Mathematical Physics 2nd Edition 1000
生物降解型栓塞微球市场(按产品类型、应用和最终用户)- 2030 年全球预测 1000
Implantable Technologies 500
Ecological and Human Health Impacts of Contaminated Food and Environments 400
Theories of Human Development 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 计算机科学 内科学 纳米技术 复合材料 化学工程 遗传学 催化作用 物理化学 基因 冶金 量子力学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3924280
求助须知:如何正确求助?哪些是违规求助? 3469072
关于积分的说明 10954815
捐赠科研通 3198415
什么是DOI,文献DOI怎么找? 1767145
邀请新用户注册赠送积分活动 856683
科研通“疑难数据库(出版商)”最低求助积分说明 795585